Ilmarinen Mutual Pension Insurance Co
PensionPosition in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1661580
HELSINKI, H9
Position in ALNY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,762,875
-$373,000 QoQ
Shares Held
12,500
0.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#259
of 780 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ilmarinen Mutual Pension Insurance Co holds $45,419,341 across 6 Biotechnology names. ALNY ranks #4 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
33,800 | $16,789,474 | |
| 2 | ARGX |
Argenx SE
|
13,800 | $12,803,226 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11,900 | $7,420,126 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
12,500 | $3,762,875 | |
| 5 | RPRX |
Royalty Pharma plc
|
60,000 | $3,364,200 | |
| 6 | INSM |
INSMED Inc
|
12,000 | $1,279,440 |
All Filings in ALNY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,762,875 | 12,500 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,135,875 | 12,500 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,970,625 | 12,500 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $9,576,000 | 21,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,847,890 | 21,000 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||